Diabetes drug may boost power of anti-depressantsMay 3rd, 2012 - 5:18 pm ICT by IANS
London, May 3 (IANS) Pioglitazone, an anti-diabetic drug which goes by the brand name Actos, boosts the power of anti-depressants in patients whether they are suffering from diabetes or not, according to a new study.
Shahin Akhondzadeh, professor at the Tehran University of Medical Sciences in Iran, and colleagues treated 40 patients with moderate to severe depression with a common antidepressant, citalopram, either by itself or with pioglitazone. Those who were also given pioglitazone over six weeks of treatment reported lower symptoms of depression.
Researchers say it has implications for how diabetes drugs which act in a similar way as Actos (pioglitazone) could be used to boost the effectiveness of existing anti-depressants. Many patients treated with available anti-depressant drugs fail to respond to medication, the journal Neuropsychopharmacology reports.
Akhondzadeh said: “Despite the advent of several antidepressant medications, the treatment of major depressive disorder (MDD) is still far from optimal. A large proportion of patients with MDD do not respond to their first medication.”
“To achieve favourable response, these patients are generally treated by either switching to another treatment or with augmentation therapy,” according to the Daily Mail.
Actos was licensed in 2000 and helps to control blood sugar levels. It belongs to a class of drugs called thiazolidinediones which are widely used for the treatment of type 2 diabetes.
Akhondzadeh said: “To the best of our knowledge, this was the first randomised controlled trial that evaluated the role of pioglitazone in patients with MDD without any significant metabolic problems.”
- Placebo can trick brain into taking it for real - Mar 27, 2012
- Diabetes drug may elevate bladder cancer risk - Jul 04, 2012
- Drug used to treat type 2 diabetes linked to heart problems - Mar 18, 2011
- Specific Vitamin E dose can benefit nonalcoholic steatohepatitis patients - Apr 29, 2010
- Diabetes or lipid-lowering medications may help treat addiction - Apr 06, 2011
- Anti-depressants ease osteoarthritis pain - Mar 23, 2012
- Diabetes medication safe for Alzheimer's patients - Sep 14, 2010
- Psychotic-like symptoms linked to poor outcomes in depression patients - Dec 07, 2010
- Anti-inflammatory drugs reduce effectiveness of antidepressants - Apr 26, 2011
- Diabetes drug 'increases heart failure risk' - Aug 21, 2009
- Popular diabetes drugs could elevate risk of heart failure and death - Dec 04, 2009
- The Diabetes Drugs, Avandia and Actos, Have The Same Amount of Risks - Aug 29, 2010
- Blood test to tell whether anti-depressants work - Dec 16, 2011
- No link between diabetes drug and rise in heart attacks - Jun 30, 2010
- Anti-depressants boost brain cells after injury - Apr 19, 2011
Tags: anti depressant drugs, anti depressants, antidepressant medications, blood sugar levels, daily mail, depressive disorder, diabetes drug, diabetes drugs, diabetic drug, major depressive disorder, mdd, metabolic problems, neuropsychopharmacology, randomised controlled trial, severe depression, symptoms of depression, tehran university of medical sciences, thiazolidinediones, treatment of type 2 diabetes, type 2 diabetes